EMA — authorised 20 September 2007
- Status: approved
EMA authorised Eraxis on 20 September 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 20 September 2007.
Vicuron Holdings is the originator. The local marketing authorisation holder may differ — check the official source linked above.